Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 2
2000 1
2004 2
2005 4
2006 7
2010 1
2012 1
2014 1
2015 1
2020 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year

Filters applied: . Clear all
Page 1
Advanced/metastatic bladder cancer: current status and future directions.
Facchini G, Cavaliere C, Romis L, Mordente S, Facchini S, Iovane G, Capasso M, D'Errico D, Liguori C, Formato R, Cicala S, Andreozzi F, Di Lauro G, Imbimbo C, Vanni M, D'Aniello C. Facchini G, et al. Among authors: formato r. Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11536-11552. doi: 10.26355/eurrev_202011_23795. Eur Rev Med Pharmacol Sci. 2020. PMID: 33275220 Free article. Review.
Penile cancer: prognostic and predictive factors in clinical decision-making.
D'Aniello C, Cavaliere C, Facchini BA, D'Errico D, Capasso M, Iovane G, Romis L, Mordente S, Liguori C, Cicala S, Formato R, Coppola P, Andreozzi F, Leo L, Montesarchio V, Di Lauro G, Pisconti S, Di Franco C, De Vita F, Vanni M, Facchini G. D'Aniello C, et al. Among authors: formato r. Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12093-12108. doi: 10.26355/eurrev_202012_23998. Eur Rev Med Pharmacol Sci. 2020. PMID: 33336727 Free article. Review.
Significance of erb-B2 immunoreactivity in cervical cancer.
Califano D, Losito S, Pisano C, Santelli G, Greggi S, Iodice F, DiVagno G, Silvestro G, Tambaro R, Formato R, Iaffaioli VR, Di Maio M, Pignata S. Califano D, et al. Among authors: formato r. Front Biosci. 2006 Sep 1;11:2071-6. doi: 10.2741/1949. Front Biosci. 2006. PMID: 16720293
Phase II study of sequential hormonal therapy with anastrozole/exemestane in advanced and metastatic breast cancer.
Iaffaioli RV, Formato R, Tortoriello A, Del Prete S, Caraglia M, Pappagallo G, Pisano A, Gebbia V, Fanelli F, Ianniello G, Cigolari S, Pizza C, Marano O, Pezzella G, Pedicini T, Febbraro A, Incoronato P, Manzione L, Ferrari E, Marzano N, Quattrin S, Pisconti S, Nasti G, Giotta G, Colucci G; Southern Italy Oncology Group. Iaffaioli RV, et al. Among authors: formato r. Br J Cancer. 2005 May 9;92(9):1621-5. doi: 10.1038/sj.bjc.6602579. Br J Cancer. 2005. PMID: 15856035 Free PMC article. Clinical Trial.
Phase I-II trial of gemcitabine-based first-line chemotherapies for small cell lung cancer in elderly patients with performance status 0-2: the G-STEP trial.
Gridelli C, Gallo C, Morabito A, Iaffaioli RV, Favaretto A, Isa L, Barbera S, Gamucci T, Ceribelli A, Filipazzi V, Maione P, Rossi A, Barletta E, Signoriello S, De Maio E, Piccirillo MC, Di Maio M, Rocco G, Vecchione A, Perrone F; G-STEP Investigators. Gridelli C, et al. J Thorac Oncol. 2012 Jan;7(1):233-42. doi: 10.1097/JTO.0b013e318233d6c2. J Thorac Oncol. 2012. PMID: 22031232 Free article. Clinical Trial.
21 results